Researchers from the UC Davis Health System have discovered a
biological link between diabetes and heart disease, which may explain
why diabetes sufferers have an increased risk for heart disease. This is
according to a study published in the journal Nature.
The
researchers found that when blood sugars are abnormally high
(hyperglycemia), this activates a biological pathway that causes
irregular heartbeats - a condition called cardiac arrhythmia - that is linked to heart failure and sudden cardiac death.
According to the World Heart Federation, people who suffer from diabetes are two to four times more likely to develop cardiovascular disease, compared with people who do not have diabetes.
The American Heart Association says that around 65% of diabetes sufferers die from heart disease or stroke, emphasizing the need for new research looking at links between the conditions.
For
this study, UC Davis researchers, alongside collaborators at the Johns
Hopkins University School of Medicine, conducted a series of experiments
to determine any biological reasons as to why diabetes sufferers are at
higher risk of cardiovascular disease.
O-GlcNAc-modified CaMKII a trigger of arrhythmias
The experiments involved detailed molecular analysis in rat and human proteins and tissues, calcium
imaging in isolated rat cardiac myocytes (cells found in muscle
tissues) that were exposed to high glucose, as well looking at whole
heart arrhythmias with optical mapping within isolated hearts and live
diabetic rates.
Their findings showed that
moderate to high blood glucose levels, similar to those found in
diabetics, triggered a sugar molecule called O-GlcNAc (O-linked
N-acetylglucosamine) in heart muscle cells to bind to a specific site on
a protein called CaMKII (calcium/calmodulin-dependent protein kinase
II).
According to the researchers, CaMKII plays an important part
in regulating normal calcium levels, electrical activity and the pumping
action of the heart.
But they found its interaction with
O-GlcNAc caused CaMKII to overactivate, causing pathological changes in
the calcium signaling system it controls. This action triggered fully
active arrhythmias within minutes.
However, the researchers say the arrhythmias were prevented by inhibiting CaMKII and its binding to O-GlcNAc.
An
additional experiment, which involved analyzing the hearts and brains
of deceased humans who had diabetes, revealed high levels of
O-GlcNAc-modified CaMKII. The highest levels were found in patients who
suffered from both heart failure and diabetes.
"Since O-GlcNAc is
directly made from glucose and serves as a major nutrient sensor in
regulating most cellular processes, it is perhaps not surprising that
attachment of this sugar to proteins is emerging as a major molecular
mechanism of glucose toxicity in diabetes," says Gerald Hart, DeLamar
professor and director of biological chemistry at Johns Hopkins
University School of Medicine, and study author.
"However, this
represents the most clear-cut mechanistic study to date of how high
glucose can directly affect the function of a critical regulatory
protein."
Findings will 'undoubtedly' lead to new treatments
Prof.
Hart notes that these findings will undoubtedly lead to development of
treatments for diabetic cardiovascular disease and potential
therapeutics for glucose toxicity in other tissues affected by diabetes,
such as the nervous system, the kidney and the retina.
Donald Bers, chair of the Department of Pharmacology at UC Davis and senior study author, says:
"The novel molecular understanding we have uncovered paves the way for new therapeutic strategies that protect the heart health of patients with diabetes.
While scientists have known for a while that CaMKII plays a critical role in normal cardiac function, ours is the first study to identify O-GlcNAc as a direct activator of CaMKII with hyperglycemia."
The study authors say that further
studies are needed, particularly to identify whether the fusion of
O-GlcNAc to CaMKII plays a part in disorders of the peripheral nervous
system, a condition that is also common in diabetics.
Medical News Today recently reported on a study detailing the discovery of a particular gene variant in type 2 diabetics that is linked to higher risk of heart disease.
Written by Honor Whiteman
Copyright: Medical News Today
No comments:
Post a Comment